Literature DB >> 27209369

The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Bong-Sung Kim1, Christian Stoppe2, Gerrit Grieb3, Lin Leng4, Maor Sauler5, David Assis6, David Simons7, Arne Hendrick Boecker3, Wibke Schulte4, Marta Piecychna4, Stephan Hager3, Jürgen Bernhagen8, Norbert Pallua3, Richard Bucala4.   

Abstract

BACKGROUND: We reported earlier that the cytokine macrophage migration inhibitory factor (MIF) is a potential biomarker in burn injury. In the present study, we investigated the clinical significance of the newly discovered MIF family member d-dopachrome tautomerase (DDT or MIF-2) and their common soluble receptor CD74 (sCD74) in severely burned patients.
METHODS: DDT and sCD74 serum levels were measured 20 severely burned patients and 20 controls. Serum levels were correlated to the abbreviated burn severity index (ABSI) and total body surface area (TBSA) followed by receiver operating characteristic (ROC) analysis. Data were supported by gene expression dataset analysis of 31 burn patients and 28 healthy controls.
RESULTS: CD74 and DDT were increased in burn patients. Furthermore, CD74 and DDT also were elevated in septic non-survivors when compared to survivors. Serum levels of DDT showed a positive correlation with the ABSI and TBSA in the early stage after burn, and the predictive character of DDT was strongest at 24h. Serum levels of CD74 only correlated with the ABSI 5 days after injury.
CONCLUSIONS: DDT may assist in the monitoring of clinical outcome and prediction of sepsis during the early post-burn period. Soluble CD74 and MIF, by contrast, have limited value as an early predictor of death due to their delayed response to burn.
Copyright © 2016 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Biomarker; Burn; CD74; DDT; MIF; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 27209369      PMCID: PMC5010466          DOI: 10.1016/j.burns.2016.02.005

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  36 in total

1.  PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment.

Authors:  A Lavrentieva; S Papadopoulou; J Kioumis; E Kaimakamis; M Bitzani
Journal:  Burns       Date:  2011-10-28       Impact factor: 2.744

Review 2.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

3.  Procalcitonin levels within 48 hours after burn injury as a prognostic factor.

Authors:  Hyun Soo Kim; Hyeong Tae Yang; Jun Hur; Wook Chun; Young-Su Ju; Seon-Hee Shin; Hee Jung Kang; Kyu Man Lee
Journal:  Ann Clin Lab Sci       Date:  2012       Impact factor: 1.256

Review 4.  The role of macrophage migration inhibitory factor in critical illness.

Authors:  Steffen Rex; Sandra Kraemer; Gerrit Grieb; Christoph Emontzpohl; Josefin Soppert; Andreas Goetzenich; Rolf Rossaint; Jürgen Bernhagen; Christian Stoppe
Journal:  Mini Rev Med Chem       Date:  2014       Impact factor: 3.862

5.  Comparison of the cytokine and chemokine dynamics of the early inflammatory response in models of burn injury and infection.

Authors:  Mehmet A Orman; Tung T Nguyen; Marianthi G Ierapetritou; Francois Berthiaume; Ioannis P Androulakis
Journal:  Cytokine       Date:  2011-06-08       Impact factor: 3.861

Review 6.  Survival from burns in the new millennium: 70 years' experience from a single institution.

Authors:  Ronald G Tompkins
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

7.  Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study.

Authors:  Robert Kraft; David N Herndon; Celeste C Finnerty; Robert A Cox; Juquan Song; Marc G Jeschke
Journal:  Shock       Date:  2015-03       Impact factor: 3.454

8.  Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.

Authors:  Norbert Pallua; Dennis von Heimburg
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

9.  Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase.

Authors:  R Kleemann; A Kapurniotu; R W Frank; A Gessner; R Mischke; O Flieger; S Jüttner; H Brunner; J Bernhagen
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

10.  Macrophage migration inhibitory factor-A potential diagnostic tool in severe burn injuries?

Authors:  Gerrit Grieb; David Simons; Andrzej Piatkowski; Jürgen Bernhagen; Guy Steffens; Norbert Pallua
Journal:  Burns       Date:  2009-06-21       Impact factor: 2.744

View more
  7 in total

Review 1.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

2.  Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia.

Authors:  Bong-Sung Kim; Pathricia V Tilstam; Kevin Arnke; Lin Leng; Tim Ruhl; Marta Piecychna; Wibke Schulte; Maor Sauler; Florian S Frueh; Gabriele Storti; Nicole Lindenblatt; Pietro Giovanoli; Norbert Pallua; Jürgen Bernhagen; Richard Bucala
Journal:  FASEB J       Date:  2020-01-21       Impact factor: 5.191

3.  Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.

Authors:  Thierry Roger; Luregn J Schlapbach; Anina Schneider; Manuela Weier; Sven Wellmann; Patrick Marquis; David Vermijlen; Fred C G J Sweep; Lin Leng; Richard Bucala; Thierry Calandra; Eric Giannoni
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

4.  D-dopachrome tautomerase from Japanese sea bass ( Lateolabrax japonicus) is a chemokine-like cytokine and functional homolog of macrophage migration inhibitory factor.

Authors:  Feng Xu; Ming-Yun Li; Jiong Chen
Journal:  Zool Res       Date:  2020-01-18

5.  Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.

Authors:  Theresa H Wirtz; Philipp A Reuken; Christian Jansen; Petra Fischer; Irina Bergmann; Christina Backhaus; Christoph Emontzpohl; Johanna Reißing; Elisa F Brandt; M Teresa Koenen; Kai M Schneider; Robert Schierwagen; Maximilian J Brol; Johannes Chang; Henning W Zimmermann; Nilay Köse-Vogel; Thomas Eggermann; Ingo Kurth; Christian Stoppe; Richard Bucala; Jürgen Bernhagen; Michael Praktiknjo; Andreas Stallmach; Christian Trautwein; Jonel Trebicka; Tony Bruns; Marie-Luise Berres
Journal:  JHEP Rep       Date:  2020-12-17

Review 6.  Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning.

Authors:  Lisa Schindler; Nina Dickerhof; Mark B Hampton; Jürgen Bernhagen
Journal:  Redox Biol       Date:  2017-12-06       Impact factor: 11.799

7.  Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis.

Authors:  Josefin Soppert; Sandra Kraemer; Christian Beckers; Luisa Averdunk; Julia Möllmann; Bernd Denecke; Andreas Goetzenich; Gernot Marx; Jürgen Bernhagen; Christian Stoppe
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.